Cytotrait
Cytotrait
Agent44Agent Readiness: 44/100. Above median. Measured by StartupHub.ai. Median 41.Biotech startup using organelle engineering to develop novel, high-value traits for agricultural crops.
About
Cytotrait is a biotechnology spinout from the University of Manchester that utilizes its proprietary Mutant Organelle Selection System (MOSS) to precisely edit chloroplast and mitochondrial genomes in plants. This technology enables the development of crops with enhanced yield, resilience, and new food traits, while potentially streamlining regulatory pathways compared to conventional nuclear genome engineering.
Key facts
At-a-glance profile data
- Website
- cytotrait.com
- Headquarters
- United Kingdom
- Founded
- 2026
- Employees
- 5
- Total funding
- $3M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 9 Mar 2026 | Seed | $3M | - |
Tech stack
Detected on cytotrait.com, last scanned 13 Sept 2026. Run your own scan
- CMS / Builders
- Squarespace
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Cytotrait raised?
Cytotrait has raised a total of $3M in funding. The most recent round on record is Seed.
How many employees does Cytotrait have?
Cytotrait has approximately 5 people on record.